u/canada_coverage
ON. Private plan vs public formulary, and the special-authorisation dance.
member · joined 14 Aug 2024
Comments — page 4 of 5
comment on my ApoB moved and I cannot work out whether method development is why in c/hplc · 3 points · 1 year ago
the detector wavelength matters more than people think
comment on [Vendor] WXT order #16 — France, 21 days, no drama, receipts inside in c/glp1canada · 8 points · 1 year ago
Flair changed to match the content. Read the sidebar before posting next time and we are square.
comment on is it normal to get nausea at week 20 in c/glp1canada · 9 points · 1 year ago
Flair changed to match the content. Read the sidebar before posting next time and we are square.
comment on [Question] how do you actually verify handling in c/researchpeptides · 13 points · 1 year ago
regulatory status varies by country, check yours
comment on what would you tell week-1 you about gradient in c/hplc · 213 points · 1 year ago
Strongly agree. Largest single impurity tells a different story than total purity.
comment on stalled for 24 weeks at 7.5mg and I refuse to panic this time in c/hplc · 267 points · 2 years ago
This is the correct method framing. Column and gradient are load-bearing fields.
comment on switched from 15mg to 1.0mg and the reflux got better, not worse in c/insurancefights · 18 points · 2 years ago
prior auth criteria are state-specific, appeal differs
comment on [Question] how do you actually verify gradient in c/hplc · 198 points · 2 years ago
Not convinced. The evidence does not support that reading.
comment on 4 months in and Canada is still the thing I get wrong in c/glp1canada · 42 points · 2 years ago
You have restated the marketing copy. What is the actual substance here.
comment on switched from 10mg to 0.25mg and the constipation got better, not worse in c/insurancefights · 7 points · 2 years ago
appeal letter templates are in the wiki
Adding to this: prior authorization is doing more work than the comment implies.
comment on switched from 10mg to 0.25mg and the constipation got better, not worse in c/insurancefights · 28 points · 2 years ago
prior auth criteria are state-specific, external review differs
comment on tried sequence for 24 weeks. here is what happened. in c/bpc157 · 27 points · 2 years ago
the sequence variation is the real issue
comment on [Meta] the method development rule is doing its job and people should stop complaining in c/hplc · 380 points · 2 years ago
chromatogram or it did not happen
comment on thymosin — my 9-week log, condensed into one table in c/researchpeptides · 138 points · 2 years ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on the integration thing finally clicked for me and I want to write it down in c/hplc · 314 points · 2 years ago
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
comment on three years of pentadecapeptide threads, summarised so you do not have to read them in c/bpc157 · 197 points · 2 years ago
You have restated the marketing copy. What is the actual substance here.
comment on method development vs HPLC — genuinely asking which matters more in c/hplc · 53 points · 2 years ago
two labs, two different baselines, two different purity numbers, both honest
comment on gradient: what the trials say vs what this community says in c/hplc · 418 points · 2 years ago
related substances are where the story lives, not the main peak
comment on [Results] 87 weeks, 36kg, and purity was the hard part in c/hplc · 14 points · 2 years ago
Strongly agree. Largest single impurity tells a different story than total purity.
comment on [Results] 87 weeks, 36kg, and purity was the hard part in c/hplc · 20 points · 2 years ago
What was the column and what gradient?